In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model

Lingxiao Chen,1,* Wei He,1,* Huichuan Jiang,1,* Longxiang Wu,1 Wei Xiong,1 Bolun Li,1 Zhihua Zhou,2 Yuna Qian3–5 1Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; 2School of Chemistry and Chemical Engineering, Hunan University of Science an...

Full description

Bibliographic Details
Main Authors: Chen L, He W, Jiang H, Wu L, Xiong W, Li B, Zhou Z, Qian Y
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/in-vivo-selex-of-bone-targeting-aptamer-in-prostate-cancer-bone-metast-peer-reviewed-article-IJN
_version_ 1818346582253240320
author Chen L
He W
Jiang H
Wu L
Xiong W
Li B
Zhou Z
Qian Y
author_facet Chen L
He W
Jiang H
Wu L
Xiong W
Li B
Zhou Z
Qian Y
author_sort Chen L
collection DOAJ
description Lingxiao Chen,1,* Wei He,1,* Huichuan Jiang,1,* Longxiang Wu,1 Wei Xiong,1 Bolun Li,1 Zhihua Zhou,2 Yuna Qian3–5 1Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; 2School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, China; 3Wenzhou Institute of Biomaterials and Engineering, Chinese Academy of Science, Wenzhou, Zhejiang 325001, China; 4School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; 5Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, Chongqing 400045, China *These authors contributed equally to this work Purpose: PB is one of the most severe complications of late stage prostate cancer and negatively impacts patient quality of life. A major challenge for the treatment of cancer bone metastasis is the management of efficient drug delivery to metastatic bone lesion. We aimed to explore the use of aptamers as promising tools to develop a targeted drug delivery system for PBs. Materials and methods: In vivo SELEX was applied to identify bone targeting aptamer in a mouse model with PBs. Results: The aptamer (designated as “PB”) with the highest bone targeting frequency in mice bearing PC3 PB was selected for further analysis. The PB aptamer specifically targeted modulated endothelial cells in response to cancer cells in the bones of mice bearing PC3 PBs. The targeting efficiency of the PB aptamer conjugated to gold particles was verified in vivo. Conclusion: This investigation highlights the promise of in vivo SELEX for the discovery of bone targeting aptamers for use in drug delivery. Keywords: aptamer, tumor endothelial targeting, drug delivery
first_indexed 2024-12-13T17:20:33Z
format Article
id doaj.art-bed1764e07ca4ab6a5651dc72c9b2962
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-13T17:20:33Z
publishDate 2018-12-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-bed1764e07ca4ab6a5651dc72c9b29622022-12-21T23:37:19ZengDove Medical PressInternational Journal of Nanomedicine1178-20132018-12-01Volume 1414915943218In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis modelChen LHe WJiang HWu LXiong WLi BZhou ZQian YLingxiao Chen,1,* Wei He,1,* Huichuan Jiang,1,* Longxiang Wu,1 Wei Xiong,1 Bolun Li,1 Zhihua Zhou,2 Yuna Qian3–5 1Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; 2School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, China; 3Wenzhou Institute of Biomaterials and Engineering, Chinese Academy of Science, Wenzhou, Zhejiang 325001, China; 4School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; 5Key Laboratory of Biorheological Science and Technology (Chongqing University), Ministry of Education, Chongqing 400045, China *These authors contributed equally to this work Purpose: PB is one of the most severe complications of late stage prostate cancer and negatively impacts patient quality of life. A major challenge for the treatment of cancer bone metastasis is the management of efficient drug delivery to metastatic bone lesion. We aimed to explore the use of aptamers as promising tools to develop a targeted drug delivery system for PBs. Materials and methods: In vivo SELEX was applied to identify bone targeting aptamer in a mouse model with PBs. Results: The aptamer (designated as “PB”) with the highest bone targeting frequency in mice bearing PC3 PB was selected for further analysis. The PB aptamer specifically targeted modulated endothelial cells in response to cancer cells in the bones of mice bearing PC3 PBs. The targeting efficiency of the PB aptamer conjugated to gold particles was verified in vivo. Conclusion: This investigation highlights the promise of in vivo SELEX for the discovery of bone targeting aptamers for use in drug delivery. Keywords: aptamer, tumor endothelial targeting, drug deliveryhttps://www.dovepress.com/in-vivo-selex-of-bone-targeting-aptamer-in-prostate-cancer-bone-metast-peer-reviewed-article-IJNProstate cancer bone metastasisaptamerbone targeting;in vivo SELEX
spellingShingle Chen L
He W
Jiang H
Wu L
Xiong W
Li B
Zhou Z
Qian Y
In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
International Journal of Nanomedicine
Prostate cancer bone metastasis
aptamer
bone targeting;in vivo SELEX
title In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
title_full In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
title_fullStr In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
title_full_unstemmed In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
title_short In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
title_sort in vivo selex of bone targeting aptamer in prostate cancer bone metastasis model
topic Prostate cancer bone metastasis
aptamer
bone targeting;in vivo SELEX
url https://www.dovepress.com/in-vivo-selex-of-bone-targeting-aptamer-in-prostate-cancer-bone-metast-peer-reviewed-article-IJN
work_keys_str_mv AT chenl invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT hew invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT jiangh invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT wul invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT xiongw invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT lib invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT zhouz invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel
AT qiany invivoselexofbonetargetingaptamerinprostatecancerbonemetastasismodel